Loading clinical trials...
Loading clinical trials...
Although poor medication adherence occurs in more than 65% of adolescent and young adults (AYA) with bipolar disorder (BD) and is associated with poor recovery, high rates of relapse, and a 5.2 fold increased suicide risk, there have been no interventions that specifically target adherence in AYA with BD. This proposal will modify and test a customized adherence enhancement (CAE) intervention developed by the investigative team and found to be effective in BD adults in a high-risk, high-need group: AYAs with BD who are poorly adherent with prescribed BD medications. The project addresses the critical need for evidence-based interventions to improve adherence in AYAs with BD and has the potential to change outcome trajectories in high-risk young people with BD as they transition to adulthood.
Age
14 - 21 years
Sex
ALL
Healthy Volunteers
No
University of Cincinnati
Cincinnati, Ohio, United States
Case Western Reserve Universty
Cleveland, Ohio, United States
Start Date
March 15, 2021
Primary Completion Date
September 1, 2023
Completion Date
September 1, 2023
Last Updated
October 10, 2024
36
ACTUAL participants
Customized Adherence Enhancement for Adolescents and Young Adults (CAE-AYA)
BEHAVIORAL
Enhanced Treatment as Usual (ETAU)
BEHAVIORAL
Lead Sponsor
Case Western Reserve University
NCT04480918
NCT07140913
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions